Jiangsu Lanfeng Bio-chemical (002513.SZ) predicts a net loss of 210 million to 290 million yuan in 2024.

Jiangsu Lanfeng Bio-chemical (002513.SZ) has released its performance forecast for the year 2024, expecting a net loss of 210 million to 290 million yuan for the full year attributable to the company's shareholders. During the reporting period, the company expects a net loss attributable to shareholders of the listed company, mainly due to a comprehensive review of various assets by the company and its subsidiaries at the end of the reporting period. Based on the principle of prudence, the company has made provisions for impairment of related assets with impairment indicators, including expected credit impairment losses and asset impairment losses, reducing the net profit attributable to shareholders of the listed company by approximately 68 million yuan for the current period.